Cellectis SA (CLLS)
4.88
+0.05
(+1.04%)
USD |
NASDAQ |
Dec 24, 12:59
4.85
-0.03
(-0.61%)
After-Hours: 13:59
Cellectis SG&A Expense (TTM): 19.93M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| EDAP TMS SA | 43.50M |
| DBV Technologies SA | 28.71M |
| Genfit SA | 21.25M |
| Ascendis Pharma A/S | 446.44M |
| Akari Therapeutics Plc | 10.20M |